Sonoma Pharmaceuticals (NASDAQ:SNOA) reported quarterly earnings results on February 10, 2026 that fell short of analyst expectations.
The Healthcare company reported earnings per share of $-0.48, missing the consensus estimate of $-0.31 by $0.17 per share. Revenue came in at $4.3M, beating the estimate of $4.3M.
Sonoma Pharmaceuticals's stock moved following the earnings release. The stock currently trades at $2.83 with a market capitalization of $6.3M.